glp 1 and heart health Cardiovascular benefits of glucagon-like peptide-1 receptor agonists GLP-1s & Heart Health: Your
Description
Earlier this year, Drucker accepted a Breakthrough Prize in Life Sciences at a glitzy event in California
The company completed an acquisition of Catalent, 9 a CDMO, valued at $16.5 billion in 2024
The unprecedented rise of GLP-1s exposes how dangerously obsolete static forecasting models have become in modern pharma
Your body breaks it down within minutes
Despite this growth, access to GLP-1RAs remains uneven globally
Two years prior to presentation, the patient started treatment for obesity with duraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
